Around the Practice: High-Risk Renal Cell Carcinoma
Around the Practice: April 21, 2021
Around the Practice: Metastatic Castrate Resistant Prostate Cancer
Advertisement
Advertisement
Trending on Urology Times
1
Mark Tyson, MD shares promising BOND-003 results in papillary NMIBC
2
CORE-008: Cretostimogene achieves high CR rate in high-risk NMIBC
3
Gemcitabine intravesical system delivers high 12-month DFS in papillary-only NMIBC
4
Modern frameworks for treating high-risk non–muscle invasive bladder cancer
5
